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The composition and turnover of arachidonic acid (AA)' within T lymphocyte
membranes vary with the state of cellular activation and influence the functional
capacity ofa cell . An early response to ligand-receptor binding ofT cells is the re-
lease ofarachidonate from (1)and theredistribution of arachidonate within (2) mem-
brane phospholipids . Changes in the content ofmembrane fatty acids, particularly
AA, havebeenshown to modify transmembrane transport processes (3), membrane
enzyme activity (4), andthecytotoxic efficiency ofTcells (5) .AA serves as aprecursor
of eicosanoids (6), stimulates T cell mitogenesis (7), and promotes the activation
of protein kinase C (PKC) (8) .
Arachidonate comprises -25% of all fatty acids within T cell membranes . It is
primarily found within T cell membranes esterified to the phosphoglycerides: phos-
phatidylcholine (PC), phosphatidylserine (PS), phosphatidylinositol (PI), and phos-
phatidylethanolamine (PE) . Intact, restingT cells incorporate trace amounts of ra-
diolabeled arachidonate into membrane phospholipids inahighly predictable pattern
(9). PC is the major recipient of arachidonate . Lesser amounts are incorporated
into PI, PE and PS. 3-5% of labeled AA remains unesterified .
The incorporation and distribution of arachidonate in T cells is a complex pro-
cess that in part depends upon the activities oftwomembrane-bound enzymes . Acyl-
coenzyme A (CoA) synthetase catalyzes the ATP-dependent production of arachi-
donoyl-CoA (10) . Acyl-CoA:lysophosphatide acyltransferase promotes the transfer
ofAA into lysophospholipids (9). The reaction catalyzed by acyl-CoA transferase
is reversible, CoA-requiring, but ATP-independent and favored ifasuitable acceptor
is present (9) .AA may also be incorporated into phospholipids byaCoA-independent
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mechanism in which aphospholipase releases arachidonate from onelipidandtransfers
the fatty acid to a lysolipid acceptor. The ultimate distribution of AA within the
phospholipid pool depends upon the availability oflysophospholipid substrate, which
in turn is governed by the rate of turnover of individual phosphoglycerides.
The turnover of AA-containing phospholipids reflects the balance between the
gain in arachidonate through the remodeling activity of acyl-CoA transferase (9)
and the release of arachidonate after metabolism of phospholipids (1). The cleavage
ofarachidonate from phospholipids is highly selective. The membrane enzyme phos-
pholipase A2 (PLA2), which shows a nonpreference for PI, acts mainly on PC and
PE to produce free AA and lyso-PC and lyso-PE, respectively (11). In contrast, a
specific phospholipase C (PLC) (reviewed in reference 12) initiates the degradation
of PI, and in concert with diacylglycerol (DAG) and monoacylglycerol lipases (13),
liberates AA.
Products of phospholipid metabolism may impact signficantly on transmembrane
signal transduction in T cells. The best characterized phospholipid ligand system
is comprised of phosphoinositides. Stimulation of T cells with specific antigens or
mitogeniclectins is accompanied by the hydrolysis ofphosphoinositol-4,5-biphosphate
(PIP2) by PLC (12), which results in the formation of inositol triphosphate (IP3),
and DAG (reviewed in references 14, 15). IP3 mobilizes Ca" from intracellular
stores (15). DAG promotes the translocation of PKC (15). PKC, activatedin thepres-
ence of Cat+ , DAG, and phospholipid, phosphorylates cellular substrates such as
the IL-2 receptor. Lyso-PC, formed by PLA2 cleavage of PC, stimulates the produc-
tion of cyclic GMP (16), a nucleotide implicated in T cell mitogenesis (17). More
recently, lyso-PC has been shown to directly augment the activity of PKC (18).
Because the movement of AA within phosphoglycerides is linked to ligand-receptor
binding and the biochemical pathways that lead to the generation of second mes-
sengers, aberrations in the metabolism of arachidonate-containing phospholipids
may be associated with and potentially contribute to abnormal T cell function. To
test this hypothesis, we have examined theincorporation, distribution, andturnover
of AA within the membrane phosphoglycerides of T cells that are known to exhibit
immunoregulatory disturbances. B220' T cells from autoimmune MRL-Ipr/lpr
mice were used as the cellular model. These T cells, which massively accumulate
in mice that are homozygous for the 1pr gene (19, 20), are Thy-1+, Ly-1 +, L3T4-,
Lyt-2- (21) and express the B220 antigen normally present on pre-B cells and B
cells (22). B220' T cells exhibit defective lymphokine production and responsive-
ness upon lectin stimulation(23-25) andhave been reported to demonstratereduced
formation of inositol phosphates and DAG after exposure to T cell mitogens (26).
The currentstudy showsthat in the absenceof stimulationwith exogenousantigens,
B220' T cells manifest a marked preference for distributing labeled arachidonate
within PI. The predilection of B220' T cells to form arachidonoyl-PI results from
greatlyincreasedconstitutive PI turnover which, in turn, appears to be due to exces-
sive PLA2-like activity.
Materials and Methods
Mice.
￿
MRL-+/+ (H-2k), MRL-1pr/lpr (H-2'`), C3H/HeN (H-2k), and BALB/c (H-2d)
mice were obtained from TheJackson Laboratory (Bar Harbor, ME). Mice were studied
at 12-14 wk of age.TOMITAYAMAGUCHI ET AL.
￿
789
Materials.
￿
Fatty acid-free BSA was obtained from Boehringer Mannheim Biochemicals
(Indianapolis, IN). Arachidonic acid (20:4), myristic acid (14:0), palmitic acid (16:0), and
stearic acid (18:0), GOA sodium salt, ATP, MgC12, MgS04, NaCl, CaC12, KCI, NaH2PO4,
NaOH, mannitol, glucose, Tris(hydroxymethyl)-aminomethane (7-9) (Tris), EGTA, PMSF,
and BME amino acids were obtained from Sigma Chemical Co. (St. Louis, MO). Fatty acid
methyl ester standard (PUFA-2) was purchased from Supelco (Bellefonte, PA). All solvents
used were HPLC grade. Goat anti-mouse IgG was purchased from Tago, Inc. (Burlingame,
CA). RA3-6B2 was obtained from American Type Culture Collection (Rockville, MD).
Fluoresceinated antiThy-1.2 was purchased from Becton-Dickinson & Co. (Mountain View,
CA). Fluorescein-conjugated MARK-1, a murine antibody to rat K chains, was obtained from
AMAC, Inc. (Westbrook, ME). PC, 1-stearoyl,2-arachidonoyl [5,6,8,9,11,12,14,15-3H(N)]
([3H] AA-PC) (91
￿
Ci/mmol), [5,6,8,9,11,12,14,15- 3H]arachidonic acid ([3H] AA) (94
Ci/mmol), [arachidonoyl-1-1' 4C] arachidonoyl coenzyme A (['4C]arachidonoyl-CoA) (53.4
Ci/mol), [choline-methyl-'4C]-sphingomyelin (50 Ci/mol) (['4C]Sph), and inositol, myo-[2-
3H(N)] ([3H]myoinositol) (15 Ci/mmol) were obtained from New England Nuclear (Boston,
MA). Lyophilized PC, PS, PI, PE, phosphatidic acid (PA), Lyso-PC, Lyso-PS, Lyso-PI, and
Lyso-PE were purchased from Avanti Polar Lipid, Co. (Birmingham, AL). Silica Gel G TLC
plates were obtained from Analtech Inc. (Newark, DE). Silica Gel 60 TLC plates were pur-
chased from Merck (Darmstadt, FRG).
Preparation ofCells.
￿
Single cell suspensions prepared from lymph nodes were freed oferythro-
cytes by osmotic lysis. T cell-enriched preparations were obtained by suspending cells
(107/ml) in Eagle's Basal Medium (BME) plus 0.02% NaN3 and 5% FCS and incubating
the mixture on 100 x 15 mm plastic petri dishes (Falcon Labware, Oxnard, CA) precoated
with 5 hg of anti-mouse Ig at 4'C for 70 min to eliminate B cells. The nonadherent cells
were recovered, washed, and the procedure was repeated. The preparations contained 92-96%
Thy-1.2* cells by immunofluorescence and cytofluorographic analyses (27). In MRL-lpr/Ipr
mice, 92 t 4% ofthe cells expressed the B220 antigen as assessed by staining with RA3-6B2
mAb (22). MRL-Ipr/lpr lymph node T cells are referred to as B220' T cells hereafter.
Nonspecific esterase staining indicated that the preparations contained between I and 3 170
macrophages.
Quantification ofPHJArachidonate within Membrane Glycerolipids.
￿
Lymph node T cells (10'/ml)
were incubated in BME at 37*C in a humidified atmosphere containing 5% C02 for varying
periods of time with 0.5 /ACi/ml of [3H]AA complexed to BSA. The suspensions were cen-
trifuged at 400 g, the supernatant was removed, and the cells were resuspended in PBS. The
suspensions were then spiked with ['4C]Sph (100,000 dpm; 0.9 nm) to assess recoveries, and
membranc lipids were extracted by the method of Bligh and Dyer (28). Organic and aqueous
phase radioactivity were quantified by liquid scintillation counting using a Beckman Instru-
ments Inc. (Fullerton, CA) LS 7500 liquid scintillation counter. The organic phase was dried
under a stream ofnitrogen, membrane lipids were resuspended in chloroform/methanol (3:1),
and spotted onto silicagel G plates. The individual phospholipid molecular species were resolved
by TLC using a solvent system consisting ofchloroform/methanol/2-propanol/0 .25% aqueous
KCI/triethylamine (90:27 :75:18:54). The radioactive TLC profiles were visualized using a
Bioscan System 200 Imaging Scanner (Washington, DC). Areas corresponding to authentic
sphingomyelin (RF 0.19), PC (RF 0.22), PS (RF 0.34), PI (RF 0.46), PA (RF 0.50), PE (RF
0.54), AA (RF 0.77), and neutral lipid (RF 0.86) were scraped from the plate, and the radio-
activity was quantified by liquid scintillation counting. The overall recovery of radioactive
phospholipid (67-72%) was not significantly different in cells from MRL-+/+ and MRL-
lpr/Ipr mice.
AssessmentoftheMolar Concentration ofAA within Phospholipids.
￿
Lipid extracts were prepared
from either fresh lymph node T cells or cells cultured in BME plus lo7o BSA for up to 2 h.
The membrane lipids were then spotted on TLC plates as described above. Individual phos-
pholipids were scraped from the plate, then eluted from the silica into chloroform/methanol
(1 :2). The silica was removed by passage through a filtration column (J. T Baker Co., Phil-
lipsburg, NJ), and the remaining silica was washed with chloroform/methanol (2:1). The
phospholipid solution was spiked with heptadecanoic acid (17:0) (10 Ecg) as an internal stan-
dard, and the organic solvents were dried under nitrogen. Fatty acid methyl esters (FAMEs)790
￿
ARACHIDONOYL-PHOSPHOLIPID METABOLISM IN B220' T CELLS
ofthe phospholipids were made by heating the individual phospholipids in 10% hydrochloric
acid in methanol (1 ml) at 100°C for 12 min (29). The reaction mixture was cooled on ice,
and the acid was neutralized using 5 N NaOH (0.5 ml). The FAMEs were twice extracted
from the aqueous phase into hexane (1 ml), and the FAME-hexane was dried under nitrogen.
The FAMEs were resuspended in hexane (50 AI) and resolved from 140 to 220°C using a
Hewlett-Packard (Palo Alto, CA) 5890A gas chromatography system equipped with a DB255
column (0.25 AM x 30 m) (J & W Scientific, Folsom, CA). Individual FAMEs were detected
by a flame ionization detector and identified by comparison of RF of known FAME stan-
dards. The quantity ofarachidonoyl-methyl esterwas determinedrelative to the heptadecanoyl-
methyl ester peak area.
Phospholipid Turnover in T Cells.
￿
T cells (10'/ml) were prelabeled with [3HJAA (0.5 pCi)
for 60 min at 37°C then washed twice. Duplicate samples of labeled cells were recultured
in acid-washed, glass test tubes at 107 cells/ml in BME containing 1% BSA. After varying
periods of time, the suspensions were centrifuged at 400 g and the supernatant was collected
for liquid scintillation counting. The cells were resuspended in PBS (1 ml), and subjected
to a Bligh-Dyer extraction. The radioactivity in the aqueous and organic phases were quantified
by liquid scintillation counting. The organic phasewas reduced under nitrogen then spotted
on TLC plates. Areas corresponding to authentic PC, PS, PI, PE, PA, AA, and neutral lipids
were scraped. The percentage of radioactivity within individual glycerolipids was quantified
by liquid scintillation counting. The molar concentration of [3H]arachidonoyl-phospholipid
was calculated from the specific activity of labeled arachidonate (94 Ci/mmol).
Acyl-CoA Lysophospholipid Transferase Activity.
￿
Lymph node T cells (2 .5 x 106/ml) were sus-
pended in a buffer (pH 7.4) consisting of mannitol (300 mM), Tris (15 mM), EGTA (5 mM),
and PMSF (0.1 mM), and the cells were cavitated at 4°C usinga cell disruption bomb (Parr
Instrument Co., Moline, IL) (30). The homogenate was centrifuged at 48,000 g for 30 min.
The supernatant was discarded and the membrane pellet was resuspended in cold PBS. Mem-
brane protein was determined by a modification of the method of Lowry (31) using a micro
BCA reagent from Pierce Chemical Co. (Rockford, IL). T cell membrane homogenates (150
Ag protein) were incubated with ['4C]arachidonoyl-CoA (0.2 AM) plus 0.25 AM each of Lyso-
PC, Lyso-PS, Lyso-PI, and Lyso-PE in PBS (1 ml) at 37°C for 60 min (32). The transferase
reaction was terminated by the addition of 3.7 ml of methanol/chloroform (2.5:1 .2). The
extraction, separation, and quantification of radiolabeled phospholipids were otherwise as
described above.
Arachidonoyl-CoA Ligase/Acyl-CoA Lysophospholipid TransferaseActivity.
￿
T cell membrane homo-
genates (150 pg protein) were incubated with [3H]AA (1 p,Ci), ATP (5.5 MM), MgCl2 (21
mM), and CoA (65 AM) in the presence or absence of 0.25 AM each of Lyso-PC, Lyso-PS,
Lyso-PI, and Lyso-PE in PBS (1 ml) at 37°C for 60 min (9). The reaction was terminated
and the phospholipids were extracted, separated,and quantified as described above.
Lyso-PI Formation.
￿
Lymph node T cells (10'/ml) were labeled for 2 h at 37°C with
[3H]myoinositol (5 ACi/ml) in medium (pH 7.2) consisting of glucose (5 mM), NaCI (145
mM), CaC12 (1 mM), KCl (5 mM), NaH2PO4 (1 MM), MgS04 (50 AM), Hepes (10 mM),
amino acids, and 1% BSA. The labelwas removed by three washes. The cells were resuspended
(107 cells/ml) in BME plus 1% BSA and cultured for up to 4 h a 37°C in a humidified at-
mosphere containing 5% CO2 . At varying times, the cells were recovered, resuspended in
PBS, spiked with [3H]AA-PC (50,000 dpm) to assess recoveries and with 10 pg each of
authentic PC, PI, and lyso-PI to provide a reference point for chromatographic analyses.
The lipids were extracted and the organic phasewas spotted onto Silica Gel 60 plates preacti-
vated with acetone. Phospholipids were resolved in solvent systems which consisted of
CHC13/CH3CH/acetic acid (65/25/10) for the first dimension and CHC13/CH30H/formic
acid (65/25/10) for the second dimension. Phospholipids were visualized by iodine vaporiza-
tion. Areas corresponding to authentic PC, PI and lyso-PI were scraped and radioactivity
was quantified by liquid scintillation counting.
Results
I'H]Arachidonate Incorporation in Intact T Cells.
￿
When intact lymph node T cells
from control MRL-+/+ mice and B220-enriched T cells from autoimmune MRL-z
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lpr/lpr mice were incubated with trace amounts of[3H]arachidonate ofhigh specific
activity, optimal incorporation of radiolabeled material occurred in both prepara-
tions at 1 h (Fig. 1, inset). At that time, 74% ofthe added label was cell-associated
in MRL-+/+ lymph node T cells and 86% in B220+ T cells from MRL-lpr/lpr
mice. The lipid extract ofcell membranes was analyzed by TLC and the radioac-
tivity within individual glycerolipidsquantified. Labeled arachidonate was incorpo-
rated primarily into PC in cells from MRL-+/+ mice followed by PE, PI, and PS
(Fig. 1). Free arachidonate comprised<5% ofthe label within the membrane. Neu-
tral lipids accounted for the remaining radioactivity. This pattern was also found
in lymph node T cells from age- and sex-matched, immunologically normal,
C3H/HeN and BALB/c mice (data not shown). Relative to cells from MRL-+/+
mice, B220+ T cells exhibited an unusual distribution oflabeled AA within their
membrane phopholipids. A marked preference for incorporating arachidonate into
PI as opposedtoPC was apparent (Fig. 1). No differenceswere found in the amount
of labeled AA distributed within PS, PE, and neutral lipids in MRL-+/+ lymph
node T cells and B220+ T cells (Fig. 1).
Speck Activity of13HJArachidonate Phospholipid Classes.
￿
The relationship between
the distribution of [3H]arachidonate within membrane phospholipids and the size
of the phosphoglyceride AA pools was examined in lymph node T cells from
MRL-+/+ mice and B220+ T cells from MRL-lpr/lpr mice. In cells from both
PC PS PI PE AA NL
FIGURE 1.
￿
Distribution and uptake of [3H]arachidonate within membrane glycerolipids ofMRL
lymph node Tcells. Lymph node Tcells(101/ml) from MRL-+/+ (closed bars) andMRL-Ipr/lpr
(open bars) mice were incubatedwith [3H]AA (0.5 pCi/ml) for60 minat 37°C. Membrane lipids
were extracted, resolved by TLC, andglycerolipidswere quantified by liquid scintillation counting.
(Inset) Thekinetics of [3H]arachidonate (0.5 pCi/ml) uptake in lymphnode T cells (107/ml) from
MRL-+/+ (closed circles) and MRL-lpr/lpr (open circles) mice is shown. Data are the mean t SE
of seven experiments. NL, neutral lipids.792
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MRL strains, PC was found to contain the largest molar quantity ofarachidonate
followed by PE andPI (Fig. 2). The amount ofAA within eachphospholipid molec-
ular species was comparable in T cells from MRL-+/+ and MRL-lpr/lpr mice.
The ratio ofthe amount oflabeled AA incorporated into a phospholipid and the
molar quantityofarachidonate within that phospholipid provides a specific activity
(33). Specific activity analysis was used to estimate the movement of arachidonate
within the phosphoglycerides ofB220+ T cells and control lymph node T cells. Cells
were cultured in the presence or absence oflabeled arachidonate for 60 min then
harvested. Phospholipid classes were separated by TLC and AA content was mea-
suredby gaschromatography. InmembranesfromMRL-+/+ Tcells, PC contained
the highest labeled/unlabeled ratio (21.2 nCi/nmol) of arachidonate, while PI con-
tained the highest specific activity (33.5 nCi/nmol) of [3H]arachidonate in B220+
T cells (Fig. 3). Although the molar concentration of arachidonic acid in PI was
less than that in either PE or PC in MRL-+/+ membranes (Fig. 2), the specific
activity of [3H]arachidonate in PI (13.9 nCi/nmol) was greater than twice that in
PE (5.3 nCi/nmol) and approached that in PC (Fig. 3). Despite the high specific
activity of PI in MRL-+/+ membranes, for every nmol of cold AA within PI,
B220+ T cells incorporated 2.5 times as much labeled AA as did control cells (Fig.
3). Thus, incorporation of[3H]AA intoTcell membranes ofMRL-+/+ and MRL-
lpr/lprmice was, inthe main, unrelatedto thesizeoftheir arachidonate-phospholipid
pools. The marked preference forMRL-lpr/lprcells todistribute labeledarachidonate
into PI and for MRL-+/+ lymph node T cells to incorporate [3H]arachidonate into
PC most likely reflected differences between cells from each strain in the rates of
turnover of one phosphoglyceride over another.
Turnover of Phospholipids in T Cellsfrom MRL Mice.
￿
The constitutive turnover of
arachidonate within membrane phospholipids was next investigated in lymph node
T cells from MRL-+/+ mice and B220+ T cells in MRL-lpr/lpr mice. Cells were
cultured inBME plus lipid-free BSAforup to 2 h. At varioustimes thesupernatants
and cell pellets were harvested, glycerolipids were resolved by TLC and quantified
byliquid scintillationcounting. Initial studies revealed that the amount ofradiolabel
lost overtime was comparable in cells from MRL-+/+ andMRL-lpr/lprmice (Fig.
4). During the culture period, the molar quantities ofcold arachidonate contained
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FIGURE 2.
￿
AA content within phos-
pholipids ofMRLlymph node T cells.
Lipid extracts were prepared from
lymph node T cells of MRL-+/+
(closed bars) and MRL-lpr/lpr (open bars)
mice. Phospholipids were isolated by
TLC, fatty acids were derivatized to
methyl esters and arachidonoyl-methyl
ester content was determined by gas
chromatography. Data are the mean t
SE of four experiments.FIGURE 3.
￿
Specific activity oflymph
node T cells. Lymph node T cells
(107/ml) from MRL-+/+ (closed bars)
andMRL-lpr/lpr (open bars)mice were
incubatedfor60 minat 37°C with and
without [3H]AA (0.5 ACi/ml). Mem-
branelipids were extractedfrom each
groupandphospholipidswere resolved
by TLC. In unlabeledcells, themolar
concentrationofarachidonic acid with-
in individual phospholipid molecular
specieswas quantified by gas chroma-
tography followingderivation offatty
acidsto methyl esters. In labeled cells,
PI
￿
theconcentrationofAA withinvarious
PC Ps
￿
PE
phospholipids wasmeasured by liquid
scintillation counting. Data are the
ratio of the nCi [3H]AA incorporated within an individual phosphoglyceride over a 60-min culture
period relative to the nanomolar concentration of arachidonate within that phospholipid. Results at
the mean t SD of two experiments performed in duplicate.
M a
within phosphoglycerides remained constant (data not shown). As expected, loss of
[3H]arachidonate-PC was significantly greater in lymph node T cells from
MRL-+/+ mice than in B220' T cells from MRL-lpr/lprmice (Fig. 5, left). In con-
trast, cells from MRL-lpr/lprmice exhibited amarked increase in the loss ofarachi-
donic acid-containing PI when compared to those from MRL-+/+ mice (Fig. 5,
right). No differences were found in the turnover ofPS, PE, or neutral lipids (data
not shown).
PHJArachidonate Incorporation in MRL- +/+ T Cell Membranes.
￿
As stated earlier,
AA may be incorporated into membrane phospholipids by the combined activities
oftwo membrane-bound enzymes. Acyl-CoA synthetase catalyzes theATP-dependent
formation ofarachidonoyl-CoA (10). This rate-limiting step is then followed by the
ATP-independent transfer of arachidonoyl-CoA into membrane lysophospholipids
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FIGURE 4.
￿
Loss of radioactivity from lymph
node T cells. Lymphnode T cells (107/ml) from
MRL-+/+ (closed circles) and MRL-!pr/lpr (open
circles) mice were prelabeled with [3H]AA (0.5
pCi/ml)at 37°C for 60 min. Thecellswere har-
vested, washed, and recultured (107/ml) at 37 °C
in BME containing 1% lipid-free BSAforup to
120min. At various times, thesupernatants were
harvested and examined for their content of ra-
dioactivity. Data are themean t SE offour ex-
periments.794
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FIGURE 5 .
￿
Phospholipid turn-
over in lymph node T cells .
Lymph node T cells from
MRL-+/+ (closed circles) and
MRL-llbr/lpr (open circles) mice
were cultured as described in
the legend for Fig . 4 . At the ini-
tiation of culture (zero time)
and at various times thereafter
the cells were harvested, lipids
were extracted, and phos-
phoglycerides were resolved and
quantified by TLC and liquid
scintillation counting, respec-
tively. The results represent the
changes in the content of
[3H]arachidonoyl-PC (left) and
[31]arachidonoyl-PI (right) dur-
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by acyl-CoA transferase (9). Transferase activity is governed primarilyby the amount
of arachidonoyl-CoA formed and by the availability of lysophospholipid substrate.
In preliminary studies we found that when lymph node T cell membranes from
MRL-+/+ mice were used as a source of acyl-CoA transferase activity and given
[I4C]arachidonoyl-CoA plus 0.25 AM each of lyso-PC, lyso-PS, lyso-PI, and lyso-
PE, PI was the dominant acceptor of arachidonate (data not shown). When lymph
node T cell membranes from MRL-+/+ mice were challenged with [3H]arachi-
donate plus 0.25 pM each of lyso-PC, lyso-PS, lyso-PI, and lyso-PE, PI was again
found to be the dominant acceptor species of arachidonate (Fig . 6, left) . However,
when membranes from MRL-+/+ lymph node T cells were incubated with
[3H]arachidonate in the absence of exogenous lysophospholipids, PC became the
primary acceptor of arachidonic acid (Fig . 6, right) . The latter result is consistent
FIGURE 6 . Acyl-CoA ligase/
acyl-CoA lysophospholipid trans-
ferase activity in MRL-+/+
lymphnodeT cells. Membrane
homogenates (150 pg protein)
from MRL-+/+ lymph node
T cells were incubated with
[3H]AA (1 ACi), ATP, MgC12
andCoA in the presence (left) or
absence (right) of0.25 pM each
oflyso-PC, lyso-PS, lyso-PIand
lyso-PE at 37'C for 60 min .
Lipids were extracted, resolved
by TLC, and quantified by liq-
uid scintillation counting. Data
are the mean t SE of four ex-
periments.TOMITAYAMAGUCHI ET AL.
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with the higher levels of lyso-PC characteristically found in cellular membranes when
compared with that of lyso-PI (34) .
PH]Arachidonate Incorporation in B220+ TCell Membranes ofMRL-lpr/lprMice.
￿
We
have shown that B220' T cells from MRL-lpr/lpr mice preferentially incorporate
labeled arachidonic acid into PI, demonstrate normal levels of AA-containing PI
and exhibit increased turnover of [3H]arachidonate-PI . These data suggest that
there is increased metabolism of PI in B220 +T cells that leads to an increase in the
availability of lyso-PI for acyl-CoA transferase . If the synthetase-transferase system
operates normally in B220+ T cells, membrane preparations would be expected to
preferentially incorporate labeled arachidonate into PI in both the presence and ab-
senceof added lysophosphatides . Consistent with this thesis, PI is the major acceptor
of [3H]AA when B220+ T cell membranes of MRL-lpr/lpr mice are cultured with
[3H]arachidonate alone (Fig. 7, right) or with label plus an equal amount of lyso-
PC, lyso-PS, lyso-PI, and lyso-PE (Fig . 7, left) .
Formation ofLyso-PIin LymphNode TCells.
￿
It remained to be shown that increased
constitutive metabolism of PI in B220+ T cells was associated with increased for-
mation oflyso-PI . Lymph node Tcells fromMRL mice were labeled with [3H]myo-
inositol . The cells were washed and recultured for up to 4 h in BME plus 1% BSA .
At the initiation of culture and after 2 and 4 h of culture, membrane lipids were
extracted, phosphoglycerides were resolved by TLC and the appearance of lyso-PI
over time was determined radiometrically. The area corresponding to authentic PI
comprised the major percentage of radioactivity in both B220' T cells (94 t 3%)
and in control lymph node T cells (82 t 4%) . The levels of labeled lyso-PI were
significantly greater in preparations ofB220+ T cells versus control cells at the ini-
tiation of culture and after 2 and 4 h of culture (Table I) .
Discussion
The results presented herein demonstrate that B220+ T cells from autoimmune
MRL-lpr/lpr mice exhibit a novel pattern of distribution of newly incorporated, la-
beled AA within their membrane phospholipids . The preference of B220' T cells
FIGURE 7 .
￿
Ligaseitransferase activity
in B220' T cells . Membrane homo-
genates (150 l~g protein) from B220'
T cells were incubated with [3H]AA in
the presence (left) or absence (right) of
lysophospholipids as outlined in the
legend for Fig. 6 . [3H]Arachidonoyl
phospholipids were resolved by TLC
and quantified by liquid scintillation
counting. Data are the mean t SE of
four experiments .796
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for forming [3H]arachidonoyl-PI over -PC was not found in lymph node T cell
membranes ofcongenic MRL-+/+ mice or in those from immunologically normal
C3H/HeN and BALB/c mice (not shown) and may be a unique property ofthese
mutant Tcellsthatmassivelyaccumulate in mice homozygous forthe lprgene (19, 20).
The cause ofthe unusual predilection ofthe B220+ Tcell PI pool for AA remains
to be fully explained. Relative to MRL-+/+ lymph node T cells, B220+ T cells ex-
hibit increased turnover of AA-containing PI in association with increased forma-
tionoflyso-PI. Inimmunologicallynormal Tcells, PI appearsto beprincipally metabo-
lizedbymembranePLC(12). Inositol phosphates and DAG are products ofthe reaction
(14). Lyso-PI is not formed in the course of PI metabolism by PLC. Our results,
therefore, indicate that in B220+ T cells enhanced turnover of PI cannot be fully
explained by a pathway that involves PLC.
Whenpharmacological doses oflyso-PC, lyso-PS, lyso-PI, andlyso-PE are simul-
taneously given to lymph node T cell membranes from autoimmune and normal
strains, lyso-PI is the dominant acceptor species for [3H]arachidonate. In the ab-
senceofexogenously addedlysophospholipids, lyso-PC is the major recipient ofAA
in T cells from normal mice. B220+ T cells, however, continue to show preferential
transfer ofarachidonate intolyso-PI. In resting T cells, the level oflyso-PC is gener-
ally verymuch greaterthan thatofanyotherlysophosphatide includinglyso-PI (34)
and labeled arachidonate is distributed primarily into PC (9). B220+ T cells exhibit
a profile that suggests a relative deficiency in lyso-PC and/or an excess of lyso-PI.
Alterations in lysophospholipid levels, in turn, may be intrinsic orthe result ofvari-
ations in the rate of phospholipid metabolism. The fact that the phospholipid AA
pools are comparable in lymph node T cells from MRL-+/+ mice and B220+ T
cellsfromMRL-1pr/1prmiceindicatesthatdifferential rates ofPC versus PI turnover
contribute significantly to thedistributionoflabeledAAwithin themembrane phos-
pholipids of each strain.
Labeling experiments with [ 3H]myoinositol suggest that PI is giving rise to in-
creased quantities oflyso-PI at an increased rate in B220+ T cells. The most direct
route for the generation oflyso-PI is through PLA2-mediated cleavage of arachi-
donate from the sn-2 position of PI. In macrophages, where signficant PLA2 ac-
tivity exists, PI is a relatively poor substrate and PC a preferred substrate for PLA2
TABLE I
Lyso-PI Formation in MRL Lymph Node T Cells
T cell source
￿
Lyso-PI detected per 107 cells cultured for:
(strain)
￿
0 h
￿
2 h
￿
4 h
fmol
MRL- + / +
￿
4.6 t 0.3
￿
4.5 t 0.7
￿
2.1 t 0.1
MRL-1pr/1pr
￿
14.1 t 0.9
￿
10.8 t 0.6
￿
4.3 t 0.3
Lymph node T cells (107/ml) from MRL mice were incubated for 2 h with
[3H]myoinositol (5 gCi/ml), washed, and cultured (107/ml) for up to 4 h at 37°C
in BME plus 1 % lipid-free BSA. At the initiation (0 h) and after 2 and 4 h cul-
ture, phospholipids were resolved by TLC and quantified by liquid scintillation
counting. Radioactivity in the organic phase of the lipid extract was 1,580 t
209 cpm in MRL- + / + T cells and 12,296 t 843 cpm in B220' T cells. Results
are the mean t SD of two experiments performed in duplicate.TOMITAYAMAGUCHI ET AL.
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(11). The turnover ofPC in cultured MRL-+/+ lymph node T cells and associated
loss ofesterified, labeled arachidonate are most likely manifestations of PLA2 ac-
tivity. The loss of[3H]arachidonate-PI in B220+ T cells also suggests PLA2-like ac-
tivity. However, in thelatter case, PI and notPC appears to bethe enzymatic target.
To our knowledge, B220+ T cells may represent the first example ofa subset ofcells
in which PLA2-like activity is preferentially directed against PI and not another
phospholipid.
The possibility that lyso-PI is beingproduced by acyl-CoA transferase-catalyzed
exchange ofarachidonic acid between PC andlyso-PI cannot be excluded. Paradox-
ically, the driving force behind such an exchange might be increased metabolism
ofPC by aPLA2, resulting in enhanced formation oflyso-PC. Ifthis were the case,
we would anticipate increased turnover ofboth PC and PI in B220+ T cells. How-
ever, specific activity analysis and direct measurements of phospholipid turnover
indicate that the loss of[3H]arachidonoyl-PC is significantly decreased in B220+ T
cells compared with that in control cells. It is therefore unlikely that augmented
production of lyso-PI in B220+ T cells is due to increased loss of PC and acceler-
ated transfer of arachidonate from PI to lyso-PC.
The contribution of enhanced constitutive turnover ofPI to the derangements
in transmembrane signal transduction that have been reported in B220+ Tcells (26)
remains to be determined. If, as the data indicate, PI is being metabolized at an
enhanced rate and PC at a decreased rate, in B220+ T cells by a PLA2-like activity,
then formation oflyso-PI should be greater than that oflyso-PC. In contrast, im-
munologically normal Tcells, which constitutively turn over PC more efficiently
than PI, would be expected to generate morelyso-PC thanlyso-PI. Thebiochemical
properties oflyso-PC suggest that it might play an important role in cellular activa-
tion. Lyso-PC is an excellent detergent (35) and is potentially capable ofincreasing
membrane fluidity. In vitro studies indicate that lyso-PC can augment PKC (18)
and guanylatecyclase(17) activities. Ifincreasedmetabolism ofPIfavors theproduction
of lyso-PI over lyso-PC in B220' T cells, signal transduction may thus be com-
promised.
Another potential consequence ofincreased PI-PLA2-like activity is that ofcom-
petition with PI-specific PLC (12) for substrate. If PI is preferentially metabolized
by PLA2, as opposed to PLC, diminished production of inositol phosphates and
DAG might occur. The latter second messengers appear to be required in order to
fully activate PKC (15). Cellular events that are thought to be coupled to PKC acti-
vation (e.g., IL-2 synthesis, IL-2 receptorexpression) couldconceivably bejeopardized
ifPI availability for PLC is limited. Simultaneous measurements ofPLC and PLA2
activities in membrane preparations ofB220+ T cells should help to define the rel-
ative capacities of these enzymes to use PI as a substrate.
In summary, the dataindicate that cellsthat manifest abnormal immune function
may also exhibit derangements in the incorporation, distribution, and metabolism
ofAA within membrane phospholipids. It remains possible that disturbances in the
movement ofarachidonate within phosphoglycerides play a role in the expression
of aberrant immunological activity.
Summary
The metabolism ofAA-containing phosphoglycerides within T cell membranes
leads to the generation of second messengers that appear to play a crucial role in798
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transmembrane signal transduction. To test the hypothesis that aberrations in the
movement of arachidonoyl-phospholipids are associated with and may potentially
contribute to abnormal T cell function, the incorporation, distribution, and turn-
over of AA within the membrane glycerolipids of cells that are known to exhibit
immunoregulatory disturbances was examined. Thy-1 + , Ly-1 + , L3T4- , Lyt-2- ,
B220+ T cells from autoimmune MRL-lpr/Ipr mice were used as the cellular model.
In contrast to control lymph node T cells, which preferentially incorporate la-
beled AA into phosphatidylcholine (PC), B220+ T cells displayed a predilection for
distributing [3H]arachidonate into phosphatidylinositol (PI). The arachidonoyl-
phospholipid pools were normal in B220+ T cells. The constitutive turnover of
[3H]arachidonoyl-PI was significantly enhanced and that of [3H]arachidonate-PC
substantially reduced in B220+ T cells compared with control cells. Using mem-
brane homogenates B220+ T cells demonstrated a functional increase in the levels
of lyso-PI. Intact B220+ T cells prelabeled with [ 3H]myoinositol and cultured in
the absence of stimulation with exogenous antigens or mitogens, exhibited increased
production of lyso-PI.
The data indicate that the preferential formation of [3H]arachidonoyl-PI in
B220 + T cells is the result of greatly increased, constitutive PI turnover that ap-
pears to be due to a membrane phospholipase A2 activity. It remains possible that
disturbances in the movement of arachidonate within phospholipids of B220+ T cells
play a role in the expression of aberrant immunological activity.
Receivedfor publication 25 September 1989 and in revisedform 11 December 1989.
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